1992 79: 2547-2554 Woodworth and DR Parkinson CF LeMaistre, C Meneghetti, M Rosenblum, J Reuben, K Parker, J Shaw, A Deisseroth, T hematologic malignancies expressing the IL-2 receptor Phase I trial of an interleukin-2 (IL-2) fusion toxin (DAB486IL-2) in http://bloodjournal.hematologylibrary.org/site/misc/rights.xhtml#repub_requests Information about reproducing this article in parts or in its entirety may be found online at: http://bloodjournal.hematologylibrary.org/site/misc/rights.xhtml#reprints Information about ordering reprints may be found online at: http://bloodjournal.hematologylibrary.org/site/subscriptions/index.xhtml Information about subscriptions and ASH membership may be found online at: reserved. Copyright 2011 by The American Society of Hematology; all rights 900, Washington DC 20036. weekly by the American Society of Hematology, 2021 L St, NW, Suite Blood (print ISSN 0006-4971, online ISSN 1528-0020), is published For personal use only. by guest on July 10, 2011. bloodjournal.hematologylibrary.org From